Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.8 SEK | -0.16% | +9.38% | +23.32% |
May. 07 | Nordic Shares Closed Up Tuesday; Storskogen Group Series B Topped Leaders | DJ |
May. 07 | Transcript : BioGaia AB, Q1 2024 Earnings Call, May 07, 2024 |
Chart calendar BioGaia AB
Upcoming events on BioGaia AB
Past events on BioGaia AB
2024-05-07 | Ex-dividend day for final dividend |
2024-05-07 | Ex-dividend day for extraordinary dividend |
2024-05-07 10:00 am | Annual General Meeting |
2024-05-07 03:30 am | Q1 2024 Earnings Call |
2024-05-07 02:00 am | Q1 2024 Earnings Release |
2024-02-07 03:30 am | Q4 2023 Earnings Call |
2024-02-07 02:00 am | Q4 2023 Earnings Release |
2023-10-20 03:30 am | Q3 2023 Sales and Revenue Call - Interim Management Statement |
2023-10-20 02:00 am | Q3 2023 Sales and Revenue Release - Interim Management Statement |
2023-07-21 03:30 am | Q2 2023 Earnings Call |
2023-07-21 02:00 am | Q2 2023 Earnings Release |
2023-06-07 | Handelsbanken Nordic Mid Small Cap Seminar |
2023-05-07 | Ex-dividend day for final dividend |
2023-05-07 | Ex-dividend day for extraordinary dividend |
2023-05-05 10:00 am | Annual General Meeting |
2023-05-05 03:30 am | Q1 2023 Sales and Revenue Call - Interim Management Statement |
2023-05-05 02:00 am | Q1 2023 Sales and Revenue Release - Interim Management Statement |
2023-03-13 | Nordic Healthcare Seminar |
2023-02-03 03:30 am | FY 2022 Earnings Call |
2023-02-03 02:00 am | FY 2022 Earnings Release |
Past dividends on BioGaia AB
2024-05-07 | Bonus Payment 5 SEK |
2024-05-07 | Annual 1.9 SEK |
2023-05-07 | Bonus Payment 1.45 SEK |
2023-05-07 | Annual 1.45 SEK |
2022-05-08 | Bonus Payment 11.29 SEK |
2022-05-08 | Annual 3.63 SEK |
2021-05-06 | Annual 3.41 SEK |
2020-05-07 | Annual 3.75 SEK |
2019-05-08 | Bonus Payment 5.95 SEK |
2019-05-08 | Annual 4.05 SEK |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 768 769 -0.07% | 747 743 0.49% | 785 760 3.32% | 1 104 1 101 0.31% | 1 297 1 281 1.23% | 1 423 |
EBITDA Million SEK | Released Forecast Spread | 258 246 4.75% | 249 257 -3.31% | 281 267 5.37% | 385 382 0.8% | 468 460 1.8% | 518 |
EBIT Million SEK | Released Forecast Spread | 243 239 1.55% | 228 242 -5.69% | 254 248 2.46% | 361 357 1.17% | 443 435 1.86% | 491 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 242 239 1.55% | 228 241 -5.75% | 253 247 2.26% | 448 363 23.24% | 469 460 2% | 516 |
Net income Million SEK | Released Forecast Spread | 187 184 1.84% | 180 186 -3.63% | 196 194 1.28% | 374 287 30.2% | 365 356 2.56% | 403 |
EPS SEK | Released Forecast Spread | 2,16 2,12 1.79% | 2,01 2,03 -0.59% | 1,94 1,92 1.36% | 3,70 2,84 30.28% | 3,62 3,53 2.55% | 3,99 |
Announcement Date | 06/02/20 | 04/02/21 | 04/02/22 | 03/02/23 | 07/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2022 Q3 |
---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 288 221 30.36% | 258 190 35.65% |
EBITDA Million SEK | Released Forecast Spread | 107 63,0 70.45% | 98,9 40,0 147.14% |
EBIT Million SEK | Released Forecast Spread | 101 58,0 74.66% | 93,7 35,0 167.81% |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 99,0 58,0 70.68% | 98,8 35,0 182.29% |
Net income Million SEK | Released Forecast Spread | 78,5 46,0 70.75% | 79,5 27,0 194.46% |
EPS SEK | Released Forecast Spread | 0,78 0,46 71.05% | 0,79 0,27 190.44% |
Announcement Date | 22/07/22 | 21/10/22 |
2024-05-12 | MEDY-TOX INC.: Q1 2024 Earnings Release (Projected) |
2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
Past sector events for BioGaia AB
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
2024-05-08 04:16 pm | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-08 04:05 pm | ZAI LAB LIMITED: Q1 2024 Earnings Release |
2024-05-08 07:55 am | VERICEL CORPORATION: Q1 2024 Earnings Release |
2024-05-07 07:30 am | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
2024-05-07 07:05 am | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-07 03:00 am | BIOTEST AG: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOG B Stock
- Calendar BioGaia AB